NL-OMON44202已完成不适用
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 211 Administered as Continuous Intravenous Infusion in Subjects with Relapsed/Refractory Gastrointestinal Adenocarcinoma - Phase 1 with AMG 211 in subjects with Gastrointestinal Adenocarcinoma
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Male or Female >/<= 18 years old;
- •Pathologically documented, diagnosed GI adenocarcinoma;
- •At least 1 measurable tumor lesion per mirRC.;Voor een volledig overzicht van alle inclusie criteria verwijs ik u naar paragraaf 4.1 van het 20130354 protocol.
排除标准
- •History of allergy or reaction to any component of the AMG 211 formulation;
- •Active infection or prior use of IV antibiotics for treatment of infection within 2 weeks prior to starting therapy with AMG 211;
- •Major surgery within 28 days of study day 1.
- •Females with a positive pregnancy test.;Voor een volledig overzicht van alle inclusie criteria verwijs ik u naar paragraaf 4.2 van het 20130354 protocol.
研究者
相似试验
招募中
1 期
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerProstate CancerJPRN-jRCT2031200384ocal Contact441
招募中
不适用
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Tarlatamab in Subjects With Small Cell Lung Cancer (DeLLphi-300)oat-cell carcinomasmall-cell carcinoma10029107Small Cell Lung CancerNL-OMON54787Amgen10
已完成
不适用
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IW-6463 when Administered to Healthy Volunteers as Single Ascending Doses with a Food Interaction Cohort, and as Multiple Ascending DosesAlzheimer's disease10057167DementiaNL-OMON47937Cyclerion Therapeutics, Inc.138
已完成
不适用
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Prostate Specific Membrane Antigen (PSMA) Half Life Extended (HLE) Bispecific T-cell Engager (BiTE) AMG 160 in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)Prostate CancerNL-OMON52552Amgen17
已完成
1 期
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCMetastatic Castration-resistant Prostate Cancer / Prostate CancerJPRN-jRCT2031200362ocal Contact212